Ivan Collado Cano

Title: Innovator Spotlight: Ivan Collado Cano

Introduction

Ivan Collado Cano is a groundbreaking inventor based in Madrid, Spain. He has made significant contributions to the field of neuroscience through his innovative research and development efforts. With a total of three patents to his name, Cano is at the forefront of creating solutions that address crucial health issues related to the central nervous system.

Latest Patents

Among his latest inventions are two patents related to excitatory amino acid receptor modulators. The first patent involves compounds of the formula (I), which modulate metabotropic glutamate receptor function and hold promise for treating various disorders of the central nervous system. The second patent also focuses on compounds of the formula (I) where R is specifically C allyl; C alkenyl; C alkynyl; phenyl-C alkyl, or phenyl-C alkenyl, including their salts and esters. These inventions are instrumental in advancing therapeutic strategies for central nervous system disorders.

Career Highlights

Ivan currently works at Eli Lilly and Company, a prominent global pharmaceutical firm known for its innovative approaches to medicine. His work at this esteemed organization allows him to collaborate with a team of dedicated professionals striving to improve healthcare outcomes.

Collaborations

Throughout his career, Cano has collaborated with notable professionals, including his coworkers Concepcion Pedregal Tercero and Alicia Marcos Llorente. Their joint efforts underscore the importance of teamwork in the pursuit of innovative solutions within the pharmaceutical industry.

Conclusion

As an inventor, Ivan Collado Cano exemplifies the spirit of innovation in the realm of neuroscience. His contributions through his patents are paving the way for advancements in treating central nervous system disorders, showcasing the pivotal role of dedicated inventors in enhancing human health.